The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as pde10 inhibitors for the treatment of schizophrenia Deposition Author(s): Bercovici, A. , Bleickardt, C. , Greenlee, W.J. , Guzzi, M. , Ho, G.D. , Hodgson, R. , Hruza, A. , Mcelroy, W. , Mckittrick, B. , Mullins, D. , Nechuta, T. , Rindgen, D. , Smith, E.M. , Smotryski, J. , Tan, Z. , Tulshian, D. , Xiao, L. , Yang, S. , Zhang, X.
Date: 2011-11-28 Method: X-RAY DIFFRACTION Resolution: 2.11 Å Organism(s): Homo Sapiens Sequences Data: 3UUO_A , 3UUO_B
The sar development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10a inhibitors for the treatment of schizophrenia Deposition Author(s): Bercovici, A. , Bleichardt, C. , Greenlee, W.J. , Guzzi, M. , Ho, G.D. , Hodgson, R. , Hruza, A. , Mullins, D. , Rindgen, D. , Seganish, W.M. , Tulshian, D. , Van Rijn, R. , Xiao, L. , Zhang, X.
Date: 2012-01-23 Method: X-RAY DIFFRACTION Resolution: 2.11 Å Organism(s): Homo Sapiens Sequences Data: 4DFF_A , 4DFF_B